CME 
JOBS 
OUTBREAKS 
PEER-TO-PEER 
QUIZZES & QUESTIONS 
MEDTECH In a review of hospitalization records in Hong Kong, Feb-July 2022, adults hospitalized for COVID and given molnupiravir or nirmatrelvir–ritonavir showed lower all-cause mortality, regardless of vaccination status. However, there was no significant reduction in ICU admission or the need for mechanical ventilation.
Peer-influenced content. Sources you trust. No registration required. This is HCN.
